[go: up one dir, main page]

WO2005062791A3 - Utilization of stem cell and fibroblast combined products and nutrients in topical compositions - Google Patents

Utilization of stem cell and fibroblast combined products and nutrients in topical compositions Download PDF

Info

Publication number
WO2005062791A3
WO2005062791A3 PCT/US2004/042421 US2004042421W WO2005062791A3 WO 2005062791 A3 WO2005062791 A3 WO 2005062791A3 US 2004042421 W US2004042421 W US 2004042421W WO 2005062791 A3 WO2005062791 A3 WO 2005062791A3
Authority
WO
WIPO (PCT)
Prior art keywords
nutrients
fibroblast
stem cell
products
utilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/042421
Other languages
French (fr)
Other versions
WO2005062791A2 (en
Inventor
Jeffrey Sebastian
Quyhn Sebastian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2005062791A2 publication Critical patent/WO2005062791A2/en
Publication of WO2005062791A3 publication Critical patent/WO2005062791A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates generally to cellular products and nutrients, and their use in the field of cosmetics. More specifically, it relates to a formulation containing stem cell and fibroblast combined products and nutrients for use in a topical composition. Such compositions generally also include a delivery vehicle adapted for topical administration, and may include a variety of other ingredients commonly found in skin care products. The products may be in the form of powders, creams, jels, etc.
PCT/US2004/042421 2003-12-20 2004-12-17 Utilization of stem cell and fibroblast combined products and nutrients in topical compositions Ceased WO2005062791A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53180203P 2003-12-20 2003-12-20
US60/531,802 2003-12-20

Publications (2)

Publication Number Publication Date
WO2005062791A2 WO2005062791A2 (en) 2005-07-14
WO2005062791A3 true WO2005062791A3 (en) 2005-08-11

Family

ID=34738703

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/042421 Ceased WO2005062791A2 (en) 2003-12-20 2004-12-17 Utilization of stem cell and fibroblast combined products and nutrients in topical compositions

Country Status (1)

Country Link
WO (1) WO2005062791A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265792B2 (en) * 2005-11-16 2016-02-23 Patricia A. Riley Integument cell regeneration formulation
WO2007097993A2 (en) * 2006-02-16 2007-08-30 The Burnham Institute Of Medical Research Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor
CN110621323B (en) * 2017-05-02 2022-10-14 田边刚士 Pharmaceutical composition and cosmetic composition
WO2019112327A2 (en) * 2017-12-06 2019-06-13 주식회사 이뮤노맥스 Method for producing cytotoxic t cells and use thereof
MY200039A (en) * 2018-12-21 2023-12-05 Cytonex Sdn Bhd Stem cell conditioned media

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions

Also Published As

Publication number Publication date
WO2005062791A2 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
AU2002343191A1 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
IL152339A0 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
WO2004101609A3 (en) Cosmetic or dermopharmaceutical composition for reducing the signs of cutaneous ageing
WO2006107825A3 (en) Skin enrichment using coq10 as the delivery system
WO2001058412A3 (en) Extracts from residues left in the production of wine
WO2004058791A3 (en) Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
WO1999026588A3 (en) Conjugated linoleic acid delivery system in cosmetic preparations
MXPA05013232A (en) Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase.
WO2004026836A3 (en) 1-pyridin-4-yl-urea derivatives
WO2007146816A3 (en) Tamanu oil products
CA2571796A1 (en) Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
PL376226A1 (en) Daily melatonin dosing units
WO2002092040A3 (en) Topical product with visual indicator
WO2003015724A1 (en) Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
NZ516136A (en) Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations
TNSN07203A1 (en) Pharmaceutical compositions for the treatment of cellulite
WO2005062791A3 (en) Utilization of stem cell and fibroblast combined products and nutrients in topical compositions
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
WO2003037288A3 (en) Cosmetic composition that mimics sebum and the use thereof
WO2003011241A8 (en) Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations
MY144531A (en) Yoghurt formulation cosmetic composition
WO2005007071A3 (en) Skin formulation
WO2007082864A3 (en) Use of chavicol as an antiseptic
WO2005004813A3 (en) Botanical extract compositions and process for preparing same
SI1771180T2 (en) Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase